• Home
  • About
  • Diagnostics
    • Ophthalmological
      • Overview
      • IgE Test
      • Lactoferrin Test
    • COVID-19 Testing Research
    • Other Areas
      • Oncological Diagnostics
      • New Test Development
  • Investors
    • Company Info
    • News
    • Media
    • Press Releases
    • SEC Filings
    • Corporate Governance
  • Contact

Research and Development Company Addresses COVID-19 Testing and Cancer Care

by IR Team | Aug 30, 2020 | Audio

John Huemoeller, CEO of AXIM Biotechnologies, discusses his company’s recently announced COVID-19 test that aims to speed up the COVID testing process that would, hopefully, lead to a COVID-19 vaccine more quickly. Huemoeller chats about AXIM’s pivot into cancer care....

About

Diagnostics

Investors

Contact

Success!

Subscribe

  • Follow
  • Follow